Incorrect username and/or password, please try again or click to reset.

Class 4 Medicines Defect Information: Crescent Pharma Ltd, SyreniRing 0.120 mg/0.015 mg per 24 hours, vaginal delivery system, EL (20)A/36

2020-08-03 13:00:12 (2 month(s) ago)

Summary

Crescent Pharma Ltd has informed us that the Patient Information Leaflet (PIL) within the packs for the below batches are missing important safety relevant text changes.

Read full MHRA article

Respond to this alert